GENES OVEREXPRESSES BY OVARIAN CANCER AND THEIR USE IN DEVELOPING NOVEL THERAPEUTICS ESPECIALLY ANTIBODIES

Details for Australian Patent Application No. 2002359777 (hide)

Owner IDEC PHARMACEUTICALS CORPORATION

Inventors REFF, Mitchell; DANIELS, Mark; MCLACHLAN, Karen

Pub. Number AU-A-2002359777

PCT Number PCT/US02/40861

PCT Pub. Number WO2003/059256

Priority 60/341,860 21.12.01 US

Filing date 23 December 2002

Wipo publication date 30 July 2003

Event Publications

3 April 2003 Complete Application Filed

  Priority application(s): 60/341,860 21.12.01 US

4 September 2003 Application Open to Public Inspection

  Published as AU-A-2002359777

9 September 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002359778-CARDIAC RHYTHM MANAGEMENT SYSTEM

2002359776-CONDUCTIMETRIC BIOSENSOR DEVICE, METHOD AND SYSTEM